This inventor holds 1 USPTO granted patent. Top assignee: Peking University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Meihuang Wang
Introduction
Meihuang Wang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biochemistry, particularly in the area of GPR39 agonists. His work has implications for various therapeutic applications, showcasing the importance of innovative research in medicine.
Latest Patents
Meihuang Wang holds a patent titled "Use of Bile Acids and Derivatives Thereof in Preparation of GPR39 Agonist." This patent highlights his innovative approach to utilizing bile acids in developing new therapeutic agents. He has 1 patent to his name, reflecting his commitment to advancing scientific knowledge.
Career Highlights
Wang is affiliated with Peking University, a leading research institution in China. His role at the university allows him to engage in cutting-edge research and collaborate with other experts in his field. His work has garnered attention for its potential impact on health and medicine.
Collaborations
Meihuang Wang has collaborated with notable colleagues, including Zhentao Zi and Yi Xian. These partnerships enhance the quality and scope of his research, fostering an environment of innovation and discovery.
Conclusion
Meihuang Wang's contributions to the field of biochemistry exemplify the spirit of innovation. His patent on GPR39 agonists demonstrates the potential for new therapeutic developments. Wang's work continues to inspire future research and advancements in medicine.